Arnold Library

Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

Mawad, Raya and Lionberger, Jack M and Pagel, John M (2013) Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia. Current hematologic malignancy reports, 8 (2). pp. 132-40. ISSN 1558-822X

[img]
Preview
Text
MawadCurrentHematolMalignantRep.pdf - Accepted Version

Download (163Kb) | Preview
Article URL: http://rd.springer.com/article/10.1007%2Fs11899-01...

Abstract

The incidence of acute myeloid leukemia (AML) is expected to increase in conjunction with our ageing population. Although it is proving to be a heterogeneous disease process, the only treatment with proven survival benefit for poor risk AML remains allogeneic hematopoietic cell transplant. Although this is presumed to be a curative strategy, many patients relapse after transplant, prompting us to examine various ways that we can improve outcomes. These efforts involve every step of AML diagnostics and therapy, including the intricate processes of conditioning, graft manipulation and immunomodulation. The hope is that improvement in these steps will ultimately improve survival and decrease relapse rates for AML patients after transplant.

Item Type: Article
Additional Information: The final publication is available at link.springer.com”
DOI: 10.1007/s11899-013-0153-6
PubMed ID: 23456518
NIHMSID: NIHMS485118
Grant Numbers: P01 CA044991
FHCRC Divisions: Clinical Research
Depositing User: Library Staff
Date Deposited: 24 May 2013 20:08
Last Modified: 24 May 2013 20:08
URI: http://authors.fhcrc.org/id/eprint/610

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy